View Author
mutation bladder patient cancer tumor bladder cancer fgfr 3 mutations grade urine recurrence study fgfr 3 mutation carcinoma fgfr 3 analysis marker progression urothelial detection stage microsatellite cystoscopy cytology follow-up disease sensitivity table result factor receptor sample fgfr 3 gene microsatellite analysis growth assay bladder tumors urology number cell carcinoma urothelial cell carcinoma diagnosis rhijn pathologist review figure alteration specificity chapter prognosis group recurrence rate fibroblast lesion surveillance expression value system frequency zwarthoff ec papilloma pathway classification month status kwast series kirkels wj eortc dysplasia zwarthoff rotterdam method department survival pathology score urine cytology thanatophoric dysplasia addition van der kwast
8 Most Recent Publications
|
Long-term follow-up of T1 high-grade bladder cancer after intravesical bacille Calmette-Guérin treatment
(Article)
Kakiashvili, D.M. Rhijn, B.W.G. van Hanna, S. Kostynsky, A. Kuk, C. Kwast, Th.H. van der Zlotta, A.R. Trottier, G. Jewett, M.A.S. Fleshner, N.E. Finelli, A. Azuero, J. Bangma, C.H. Vajpeyi, R. Alkhateeb, S. |
2011-02-01
|
|
FGFR3, HRAS, KRAS, NRAS AND PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy
(Article)
Kompier, L.C. Lurkin, I. Aa, M.N.M. van der Rhijn, B.W.G. van Kwast, Th.H. van der Zwarthoff, E.C. |
2010-11-18
|
|
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer
(Article)
Rhijn, B.W.G. van Zuiverloon, T.C.M. Vis, A.N. Radvanyi, F. Leenders, G.J. van Ooms, B.C.M. Kirkels, W.J. Lockwood, G.A. |
2010-09-01
|
|
Pathological stage review is indicated in primary pT1 bladder cancer
(Article)
Rhijn, B.W.G. van Kwast, Th.H. van der Kakiashvili, D.M. Fleshner, N.E. Aa, M.N.M. van der Alkhateeb, S. Bangma, C.H. Jewett, M.A.S. Zlotta, A.R. |
2010-07-01
|
|
The Pathologist's Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading
(Article)
Rhijn, B.W.G. van Leenders, G.J. van Ooms, B.C.M. Kirkels, W.J. Zlotta, A.R. Boeve, E.R. Jöbsis, A.C. Kwast, Th.H. van der |
2010-06-01
|
|
Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial
(Article)
Aa, M.N.M. van der Steyerberg, E.W. Bangma, C.H. Rhijn, B.W.G. van Zwarthoff, E.C. Kwast, Th.H. van der |
2010-01-01
|
|
A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine
(Article)
Oers, J.M.M. van Lurkin, I. Exsel, A.J.A. van Nijsen, Y. Rhijn, B.W.G. van Aa, M.N.M. van der Zwarthoff, E.C. |
2005-11-01
|
|
Molecular Diagnosis and Prognosis of Bladder Cancer : towards the implementation of molecular markers in clinical practice
(Doctoral Thesis)
Rhijn, B.W.G. van |
2005-06-01
|
